ELUT
Price
$1.04
Change
+$0.04 (+4.00%)
Updated
Jun 23, 04:06 PM (EDT)
Capitalization
44.21M
50 days until earnings call
Intraday BUY SELL Signals
RPID
Price
$1.70
Change
-$0.00 (-0.00%)
Updated
Jun 23, 04:15 PM (EDT)
Capitalization
84.95M
38 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELUT vs RPID

ELUT vs RPID Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ELUT vs. RPID commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELUT is a StrongBuy and RPID is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (ELUT: $1.00 vs. RPID: $1.71)
Brand notoriety: ELUT and RPID are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ELUT: 61% vs. RPID: 104%
Market capitalization -- ELUT: $44.21M vs. RPID: $84.95M
ELUT [@Medical/Nursing Services] is valued at $44.21M. RPID’s [@Medical/Nursing Services] market capitalization is $84.95M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $152.98B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELUT’s FA Score shows that 0 FA rating(s) are green whileRPID’s FA Score has 0 green FA rating(s).

  • ELUT’s FA Score: 0 green, 5 red.
  • RPID’s FA Score: 0 green, 5 red.
According to our system of comparison, ELUT is a better buy in the long-term than RPID.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELUT’s TA Score shows that 5 TA indicator(s) are bullish while RPID’s TA Score has 4 bullish TA indicator(s).

  • ELUT’s TA Score: 5 bullish, 5 bearish.
  • RPID’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ELUT and RPID are a good buy in the short-term.

Price Growth

ELUT (@Medical/Nursing Services) experienced а +3.25% price change this week, while RPID (@Medical/Nursing Services) price change was -0.87% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.19%. For the same industry, the average monthly price growth was -3.86%, and the average quarterly price growth was -16.34%.

Reported Earning Dates

ELUT is expected to report earnings on Aug 12, 2026.

RPID is expected to report earnings on Jul 31, 2026.

Industries' Descriptions

@Medical/Nursing Services (-0.19% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RPID($84.9M) has a higher market cap than ELUT($44.2M). ELUT YTD gains are higher at: 44.363 vs. RPID (-41.207). ELUT has higher annual earnings (EBITDA): -20.21M vs. RPID (-43.61M). RPID has more cash in the bank: 41.2M vs. ELUT (28.5M). ELUT has less debt than RPID: ELUT (4.22M) vs RPID (24.1M). RPID has higher revenues than ELUT: RPID (30.5M) vs ELUT (12.5M).
ELUTRPIDELUT / RPID
Capitalization44.2M84.9M52%
EBITDA-20.21M-43.61M46%
Gain YTD44.363-41.207-108%
P/E RatioN/AN/A-
Revenue12.5M30.5M41%
Total Cash28.5M41.2M69%
Total Debt4.22M24.1M18%
TECHNICAL ANALYSIS
Technical Analysis
ELUTRPID
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
87%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 16 days ago
88%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
84%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ELUT
Daily Signal:
Gain/Loss:
RPID
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGEIX10.36N/A
N/A
Polen Emerging Markets Growth Inst
BEGIX18.07N/A
N/A
Sterling Capital Equity Income Instl
FSNIX18.85N/A
N/A
Fidelity Advisor Asset Manager 60% I
TLACX12.30N/A
N/A
Transamerica Large Core ESG A
ETNHX50.18N/A
N/A
Eventide Healthcare & Life Sciences N

ELUT and

Correlation & Price change

A.I.dvisor tells us that ELUT and XAIR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELUT and XAIR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELUT
1D Price
Change %
ELUT100%
-5.66%
XAIR - ELUT
29%
Poorly correlated
+8.61%
STRRP - ELUT
23%
Poorly correlated
+1.59%
STRR - ELUT
23%
Poorly correlated
-1.40%
HSDT - ELUT
23%
Poorly correlated
+0.62%
RPID - ELUT
23%
Poorly correlated
-0.29%
More

RPID and

Correlation & Price change

A.I.dvisor tells us that RPID and QSI have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RPID and QSI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPID
1D Price
Change %
RPID100%
-0.29%
QSI - RPID
32%
Poorly correlated
-7.79%
ISRG - RPID
30%
Poorly correlated
-0.94%
MBOT - RPID
28%
Poorly correlated
-0.54%
CDNA - RPID
27%
Poorly correlated
-4.24%
GH - RPID
27%
Poorly correlated
-2.24%
More